Anzeige
Mehr »
Login
Freitag, 03.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Schnelle Produktionsaufnahme: Multi-Tenbagger-Potenzial direkt in Spanien?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
224 Leser
Artikel bewerten:
(0)

Surgical Theater Received Approval to Market the Surgical Navigation Advanced Platform (SNAP) and SuRgical Planner (SRP) Systems from the Israeli Ministry of Health

SNAP and SRP enables surgeons to apply patient-specific surgical plans during actual surgeries with the ability to see and know what comes next in the surgical field

TEL AVIV, Israel, June 24, 2019 /PRNewswire/ -- Surgical Theater is very excited to announce the Medical Device Division of the Israeli Ministry of Health approved marketing of the Surgical Navigation Advanced Platform (SNAP) and SuRgical Planner (SRP) systems. To lead this charge, Eli Moshe has joined Surgical Theater as our new Senior Vice President & GM, Europe and Middle East to manage sales efforts within Europe and Israel. Tzamal Medical Ltd has been selected as the local agent and importer for Israel.

"The approval of SRP and SNAP in Israel and the appointment of Eli Moshe as GM, come at a very pivotal time for Surgical Theater," said Moty Avisar, CEO and Co-Founder of Surgical Theater. "We are very excited to grow our global presence and have no doubt Mr. Moshe will be a great catalyst in accelerating that growth. Increasing numbers of surgeons across the world will be able to use this novel technology to advance the way they perform surgeries."

Eli Moshe brings 15-plus years of experience in the field, leading sales, marketing and operations teams. Prior to joining Surgical Theater, Mr. Moshe was the Country General Manager in Israel for Hitachi Vantara. Like the founders of Surgical Theater, Mr. Moshe also comes with military background as a rank of Lieutenant Colonel. He will be overseeing sales and R&D for the EME market at the European Headquarters in Israel.

"As an Israeli, I am especially excited & proud that Israel has been chosen as the HQ for the Sales & Development for the region," said Eli Moshe. "Our technology will be one of the most important products for planning and performing complex surgeries in the human body: including brain, heart and spinal surgery. I am honored to be part of this team, leading global expansion in EME."

Precision VR is a novel visualization platform that allows patients and their surgeons to step into the patient's complex diagnosis and to walk together in a 360-degree, Virtual Reality reconstruction of the patient's anatomy. When wearing the VR headset, a VR-empowered physician and patient can tour a patient's pathology. By simply turning their head from side to side, the patient can further explore their anatomy as the surgeon explains and demonstrates the planned surgical path, which the medical team will utilize during the procedure. This shared "walk-in" through the pathology is proven to increase patient satisfaction, improve patient engagement and improve a hospital's financial performance.

Medical Institutions across Europe and the U.S., including George Washington University Hospital, UCSF Benioff Children's Hospital, Stanford Medical Center, Houston Methodist, NYU, University Hospitals, Mt. Sinai and Hoag Hospital are utilizing Surgical Theater's Precision VR throughout the patient treatment continuum.

About Surgical Theater
Surgical Theater, the market leader in virtual and augmented reality healthcare services, is the first to combine cutting-edge fighter jet flight simulation technology with a patient's own anatomy scans. Rendered from comprehensive combined modalities of CT, MRI as well as advanced post processing images such as DTI and BOLD, the 360° virtual reality fly-through is designed to allow surgeons to walk and fly-through a reconstruction of the patient's own anatomy and pathology. While wearing the VR headset, a VR-empowered physician and patient, walk together into the space between vascular structures, standing between the arteries and the tumor, or aneurysm. By simply turning their head from side to side and/or up and down, the patient can further explore their own anatomy, as the surgeon explains and demonstrates the planned surgical path that the medical team will use during their procedure. This 360° visual representation gives the patient and their families an informative and deep understanding of their condition, by visually answering questions regarding surgical approaches and other medical concerns.

Recent developments of the Surgical Theater line of products includes the utilization of advanced Augmented Reality (AR) techniques. By fusing Surgical Theater's proprietary CT/MRI based 360°degree patient-specific model with the image from the operating room microscope, synchronized Augmented Reality is achieved, which allows the surgeon to see structures that are hidden behind the pathology. For example, the surgeon can see the vessel that is hidden behind the tumor, and therefore can prepare to protect it during tumor removal, potentially preventing adverse effects. SynchronizAR, a one-of-a-kind solution, supports a surgeon's challenging and complex mission to remove the pathology while preserving the peripheral vital structures.

Precision VR is proven to increase patient satisfaction, improve patient engagement, surgical plans and a hospital's financial performance

Find out more at www.SurgicalTheater.net and on Facebook at www.facebook.com/SurgicalTheater

Instagram https://www.instagram.com/surgicaltheater/

LinkedIn https://www.linkedin.com/company/surgical-theater/

Logo - https://mma.prnewswire.com/media/831463/Surgical_Theater_Logo.jpg

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2019 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.